Advertisement BioSilta introduces EnPresso Yeast Defined Tablet - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

BioSilta introduces EnPresso Yeast Defined Tablet

BioSilta, a spin-out company from the University of Oulu in Finland, has released EnPresso Y Defined Tablet medium designed for protein production in yeast, such as Pichia pastoris.

The EnPresso Y Defined is a pre-sterilized tablet having an extended shelf-life and can be added directly to sterile water to create an instant microbial medium ready for inoculation and cultivation.

The product is made using EnBase technology, which is based on providing an enzymatic-controlled glucose supply in a fed-batch type manner, enabling an extended growth period and promoting higher final cell density.

EnBase technology also helps in bioprocess scale-up, protein production and optimization, enzyme screening, protein crystallography, plasmid production and brewery contaminant detection.